IRIS Accounts Production v25.1.4.42 11698133 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh116981332023-12-31116981332024-12-31116981332024-01-012024-12-31116981332022-12-31116981332023-01-012023-12-31116981332023-12-3111698133ns15:EnglandWales2024-01-012024-12-3111698133ns14:PoundSterling2024-01-012024-12-3111698133ns10:Director12024-01-012024-12-3111698133ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3111698133ns10:SmallEntities2024-01-012024-12-3111698133ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3111698133ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3111698133ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3111698133ns10:FullAccounts2024-01-012024-12-3111698133ns10:Director22024-01-012024-12-3111698133ns10:Director32024-01-012024-12-3111698133ns10:RegisteredOffice2024-01-012024-12-3111698133ns5:CurrentFinancialInstruments2024-12-3111698133ns5:CurrentFinancialInstruments2023-12-3111698133ns5:Non-currentFinancialInstruments2024-12-3111698133ns5:Non-currentFinancialInstruments2023-12-3111698133ns5:ShareCapital2024-12-3111698133ns5:ShareCapital2023-12-3111698133ns5:RetainedEarningsAccumulatedLosses2024-12-3111698133ns5:RetainedEarningsAccumulatedLosses2023-12-3111698133ns5:LandBuildingsns5:ShortLeaseholdAssets2023-12-3111698133ns5:PlantMachinery2023-12-3111698133ns5:ComputerEquipment2023-12-3111698133ns5:LandBuildingsns5:ShortLeaseholdAssets2024-01-012024-12-3111698133ns5:PlantMachinery2024-01-012024-12-3111698133ns5:ComputerEquipment2024-01-012024-12-3111698133ns5:LandBuildingsns5:ShortLeaseholdAssets2024-12-3111698133ns5:PlantMachinery2024-12-3111698133ns5:ComputerEquipment2024-12-3111698133ns5:LandBuildingsns5:ShortLeaseholdAssets2023-12-3111698133ns5:PlantMachinery2023-12-3111698133ns5:ComputerEquipment2023-12-3111698133ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3111698133ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3111698133ns5:Non-currentFinancialInstruments2024-01-012024-12-3111698133ns5:Secured2024-12-3111698133ns5:Secured2023-12-31
REGISTERED NUMBER: 11698133 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2024

for

Define Medical Ltd

Define Medical Ltd (Registered number: 11698133)






Contents of the Financial Statements
for the Year Ended 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Define Medical Ltd

Company Information
for the Year Ended 31 December 2024







DIRECTORS: B Dhillon
A Dhillon
E Billette





REGISTERED OFFICE: Wendover House
24 London End
Beaconsfield
Buckinghamshire
HP9 2JH





REGISTERED NUMBER: 11698133 (England and Wales)





ACCOUNTANTS: Verinder Powell Associates Ltd
Suite 5 Corum 2
Corum Office Park
Crown Way
Warmley
Bristol
BS30 8FJ

Define Medical Ltd (Registered number: 11698133)

Balance Sheet
31 December 2024

31.12.24 31.12.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 309,583 464,258

CURRENT ASSETS
Debtors 5 1,311,419 518,352
Cash at bank and in hand 278,814 33,139
1,590,233 551,491
CREDITORS
Amounts falling due within one year 6 1,678,314 463,807
NET CURRENT (LIABILITIES)/ASSETS (88,081 ) 87,684
TOTAL ASSETS LESS CURRENT LIABILITIES 221,502 551,942

CREDITORS
Amounts falling due after more than one
year

7

(330,772

)

(482,553

)

PROVISIONS FOR LIABILITIES - (69,085 )
NET (LIABILITIES)/ASSETS (109,270 ) 304

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings (109,272 ) 302
(109,270 ) 304

Define Medical Ltd (Registered number: 11698133)

Balance Sheet - continued
31 December 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:





E Billette - Director


Define Medical Ltd (Registered number: 11698133)

Notes to the Financial Statements
for the Year Ended 31 December 2024

1. STATUTORY INFORMATION

Define Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

There have been no material departures from the Financial Reporting Standard 102 1A.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

The company recognises revenue when:
- the amount of revenue can be reliably measured;
- it is probable that future economic benefits will flow to the entity;
- and specific criteria have been met for each of the company's activities.

Tangible fixed assets
Tangible fixed assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses. The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Leasehold improvements- Straight line over 15 years
Plant and machinery- 25% on cost
Computer equipment- 25% on cost


Define Medical Ltd (Registered number: 11698133)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The directors are satisfied that the company has adequate resources to continue to operate for the foreseeable future. The financial statements have therefore been prepared on a going concern basis.

Define Medical Ltd (Registered number: 11698133)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing. Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges. Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Finance income and costs policy
Interest income and expenses are recognised using the effective interest rate method.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2023 - 6 ) .

4. TANGIBLE FIXED ASSETS
Leasehold Plant and Computer
improvements machinery equipment Totals
£    £    £    £   
COST
At 1 January 2024 54,907 773,013 6,019 833,939
Additions - - 773 773
At 31 December 2024 54,907 773,013 6,792 834,712
DEPRECIATION
At 1 January 2024 6,436 359,282 3,963 369,681
Charge for year 3,661 150,365 1,422 155,448
At 31 December 2024 10,097 509,647 5,385 525,129
NET BOOK VALUE
At 31 December 2024 44,810 263,366 1,407 309,583
At 31 December 2023 48,471 413,731 2,056 464,258

Define Medical Ltd (Registered number: 11698133)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade debtors - 13,613
Other debtors 1,311,419 504,739
1,311,419 518,352

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Bank loans and overdrafts 277,177 103,372
Hire purchase contracts 162,796 135,500
Trade creditors 102,429 60,065
Taxation and social security 16,586 38,795
Other creditors 1,119,326 126,075
1,678,314 463,807

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.12.24 31.12.23
£    £   
Bank loans 17,588 63,105
Hire purchase contracts 313,184 419,448
330,772 482,553

Included in bank loans in notes 6 and 7 is a combined balance of £29,429 (2023 - £49,050) which is guaranteed by the government and unsecured.

8. SECURED DEBTS

The following secured debts are included within creditors:

31.12.24 31.12.23
£    £   
Hire purchase contracts 475,980 554,948
Other loans 265,336 117,427
741,316 672,375

Other loans and hire purchase contracts are secured over the assets to which they relate.

Define Medical Ltd (Registered number: 11698133)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

9. PENSION COMMITMENTS

The entity operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the entity in an independently administered fund. Contributions totalling £262 (2023 - £5,439) were payable to the fund at the reporting date.

10. RELATED PARTY DISCLOSURES

Loans to related parties



Key
management

Other related
parties


Total
2024 £ £ £
At start of period 146,592 30,233 176,825
Advanced 638,215 145,387 783,602
Repaid (729,688 ) (175,620 ) (905,308 )
At end of period 55,119 - 55,119


Key
management

Other related
parties


Total
2023 £ £ £
At start of the period 66,524 9,138 75,662
Advanced 147,814 21,095 168,909
Repaid (67,746 ) - (67,746 )
At end of period 146,592 30,233 176,825

The loans to key management is repayable on demand and interest is charged on loan balances owing to the company that exceed £10,000. Interest is charged at the HMRC prevailing rate.

The loans to other related parties are interest free and repayable on demand.